Search results
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
St. Joseph News-Press· 47 minutes agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387,...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 21 hours agoThe drug is called lorlatinib, and the trial team says it’s setting a “new benchmark for targeted...
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
Clinical Trials Arena via Yahoo Finance· 5 days agoRecently, Medidata expanded its partnership with contract research organisation Worldwide Clinical...
HonorHealth among 1st to implant new stroke prevention stent
Becker’s Hospital Review· 1 day agoThe device is a non-surgical, catheter-based implant...arteries connected to the neck and brain. It is an experimental treatment for carotid artery stenosis or carotid artery disease being piloted ...
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in...
Digital Journal· 7 days agoThe clinical trial protocol was submitted for review and approval by the institutional review board (IRB) in the USA...
MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side...
Valley City Times Record· 2 days agoCHICAGO, June 2, 2024 /PRNewswire/ -- Leading international medical research company, MEDSIR, today...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA PR Newswire CAMBRIDGE, Mass., June 2, 2024 CAMBRIDGE, Mass., June 2, 2024 ...
BMS stakes $80m on Prothena’s neurodegenerative candidate
Pharmaceutical Technology via Yahoo Finance· 6 days agoBMS’ Neuroscience Thematic Research Center...the US licence for Prothena’s PRX-005 for $80m in June...
... Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in...
KOLR - KSFX Ozarks· 3 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC-01 clinical ...
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
WLNS Lansing· 3 days agoThe company will showcase the latest clinical trial findings for IMC001 in a poster presentation and...